3rd Circ. Says ERISA Allows 'Catalyst Theory' Fees

The Third Circuit reversed a district court ruling Friday, finding that hemophiliacs and pharmacies who sued insurers that denied their claims for blood-clotting medications are eligible for $350,000 in attorneys' fees...

Already a subscriber? Click here to view full article